Friday, March 27, 2015 11:19 AM

As the number of new medicines introduced in Europe rises, governments are finding it increasingly difficult to afford them, according to a comprehensive study released today by the WHO Regional Office for Europe. The study illustrates the challenges for national health systems, with specific examples, and shows that few countries in the WHO European Region have mechanisms in place to evaluate the cost-effectiveness of new drugs; this hampers the value-assessment and decision-making processes.

Friday, March 27, 2015 11:12 AM

Genomics England has announced a new collaboration as part of the 100,000 Genomes Project to accelerate the development of new diagnostics and treatments for patients. Ten pharma and biotech companies have come together to create the Genomics Expert Network for Enterprises (GENE) Consortium to oversee a year-long industry trial.

Thursday, March 26, 2015 03:00 PM

New treatments, diagnostics and medical technologies are set to benefit from an investment of $47 million through the Biomedical Catalyst (BMC)—a partnership between the Medical Research Council (MRC) and Innovate U.K. This MRC and Innovate U.K. funding will be further boosted by over $12 million of investment leveraged from industry, bringing the total investment for this round to $59 million.

Thursday, March 26, 2015 02:57 PM

The National Institute of Mental Health (NIMH) has issued a new strategic plan for research. Informed by the successes and challenges of recent years, the new plan updates the strategic objectives of its 2008 predecessor with the aim of balancing the need for long-term investments in basic research with urgent mental health needs.

Thursday, March 26, 2015 02:56 PM

Parexel International, a Boston-based global CRO, has signed a definitive agreement to acquire all of the business assets of privately-owned Quantum Solutions India (QSI), a provider of specialized pharmacovigilance services.

Thursday, March 26, 2015 02:55 PM

CluePoints, a Belgium-based provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials, has partnered with the Alliance for Clinical Research Excellence and Safety (ACRES), a Massachusetts-based nonprofit dedicated to building a stakeholder-driven integrated global system for clinical research.

Thursday, March 26, 2015 02:54 PM

GlaxoSmithKline is encouraging academic scientists in Europe, Canada and the U.S. to submit their novel early drug discovery research proposals into its third annual Discovery Fast Track Challenge—a program designed to accelerate the translation of early-stage research into game-changing new medicines. The challenge provides a new template for drug discovery as it seeks to rapidly uncover the best opportunities for discovery research.

Thursday, March 26, 2015 02:52 PM

Sun Pharmaceutical Industries has begun the integration of Ranbaxy's business following the successful closure of its merger. The integration, planned by Sun Pharma since the announced merger in April 2014, will focus on supporting strong growth. According to Sun Pharma, the merger has fortified its position as the world's fifth largest specialty generic pharmaceutical company and the top ranking Indian pharma company.

Thursday, March 26, 2015 02:51 PM

Two Swedish companies, Recipharm, a contract development and manufacturing organization (CDMO), and Adroit Science, a provider of laboratory and consultancy services, have formed a new strategic collaboration.

Featured Jobs

About CenterWatch News Online:
Developed by CenterWatch, the trusted experts and recognized leaders in clinical research news and analysis, CenterWatch News Online (formerly Clinical Trials Today) is a one-stop, comprehensive resource for clinical research professionals spanning all sectors of the clinical trials industry.

Order Custom PDF Reprints:
CenterWatch offers custom PDF reprints of any new or archived article appearing on CenterWatch News Online. This document can be posted on your company's Intranet or web site or used in corporate marketing promotions. To purchase a custom PDF reprint, contact Sales at sales@centerwatch.com or (617) 948-5100.